Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Organogenesis Holdings Inc.
Bear Case (25th pct.)
122.0% vs price
Base Case (Median)
216.1% vs price
Bull Case (75th pct.)
234.1% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.99 | 216.2% | High (40%) |
| EV/FCF | $3.33 | 252.0% | Medium (20%) |
| Earnings Power Value | $1.20 | 27.1% | Medium (50%) |
Based on 3 out of 7 methods, ORGO appears undervalued at the current price of $0.95. The base case fair value of $2.99 implies 216.1% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.